{"id":1805,"date":"2025-01-16T13:38:57","date_gmt":"2025-01-16T11:38:57","guid":{"rendered":"https:\/\/aumed.cz\/?p=1805"},"modified":"2025-01-16T13:38:59","modified_gmt":"2025-01-16T11:38:59","slug":"aumed-a-s-has-received-permission-for-a-clinical-trial-phase-iii-of-the-medicinal-product-tfi","status":"publish","type":"post","link":"https:\/\/aumed.cz\/en\/aumed-a-s-has-received-permission-for-a-clinical-trial-phase-iii-of-the-medicinal-product-tfi\/","title":{"rendered":"AUMED, a.s. has received permission for a clinical trial, phase III, of the medicinal product TFI"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Based on the submitted application and the supplied documents, the State Institute for Drug Control (Czech Republic) has authorized a clinical trial, phase III, of the medicinal product TFI (Transfer Factor) lyophilized mucoadhesive tablet for buccal-oral administration in January 2025. The new medicinal product is based on the results of AUMED&#8217;s own research activities in the field of transfer factors. The purpose of this study will be to confirm the efficacy of the medicinal product TFI by demonstrating superiority over placebo. AUMED, a.s. would like to successfully complete the study and proceed with the registration process of the new medicinal product during this year.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Based on the submitted application and the supplied documents, the State Institute for Drug Control (Czech Republic) has authorized a&#8230;<\/p>\n","protected":false},"author":3,"featured_media":1604,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-1805","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AUMED, a.s. has received permission for a clinical trial, phase III, of the medicinal product TFI - Aumed, a.s.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AUMED, a.s. has received permission for a clinical trial, phase III, of the medicinal product TFI - Aumed, a.s.\" \/>\n<meta property=\"og:description\" content=\"Based on the submitted application and the supplied documents, the State Institute for Drug Control (Czech Republic) has authorized a...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/\" \/>\n<meta property=\"og:site_name\" content=\"Aumed, a.s.\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-16T11:38:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-16T11:38:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aumed.cz\/wp-content\/uploads\/2022\/05\/lyof-tablety-v\u00fdsledek-TRIA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"5075\" \/>\n\t<meta property=\"og:image:height\" content=\"2822\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marek Vronka\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marek Vronka\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/aumed.cz\\\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/aumed.cz\\\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\\\/\"},\"author\":{\"name\":\"Marek Vronka\",\"@id\":\"https:\\\/\\\/aumed.cz\\\/#\\\/schema\\\/person\\\/bc33bf2b3820f9b1a79abf1f5d855f94\"},\"headline\":\"AUMED, a.s. has received permission for a clinical trial, phase III, of the medicinal product TFI\",\"datePublished\":\"2025-01-16T11:38:57+00:00\",\"dateModified\":\"2025-01-16T11:38:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/aumed.cz\\\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\\\/\"},\"wordCount\":122,\"image\":{\"@id\":\"https:\\\/\\\/aumed.cz\\\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/aumed.cz\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/lyof-tablety-v\u00fdsledek-TRIA.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/aumed.cz\\\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\\\/\",\"url\":\"https:\\\/\\\/aumed.cz\\\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\\\/\",\"name\":\"AUMED, a.s. has received permission for a clinical trial, phase III, of the medicinal product TFI - Aumed, a.s.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/aumed.cz\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/aumed.cz\\\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/aumed.cz\\\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/aumed.cz\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/lyof-tablety-v\u00fdsledek-TRIA.jpg\",\"datePublished\":\"2025-01-16T11:38:57+00:00\",\"dateModified\":\"2025-01-16T11:38:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/aumed.cz\\\/#\\\/schema\\\/person\\\/bc33bf2b3820f9b1a79abf1f5d855f94\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/aumed.cz\\\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/aumed.cz\\\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/aumed.cz\\\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/aumed.cz\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/lyof-tablety-v\u00fdsledek-TRIA.jpg\",\"contentUrl\":\"https:\\\/\\\/aumed.cz\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/lyof-tablety-v\u00fdsledek-TRIA.jpg\",\"width\":5075,\"height\":2822},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/aumed.cz\\\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Dom\u016f\",\"item\":\"https:\\\/\\\/aumed.cz\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AUMED, a.s. has received permission for a clinical trial, phase III, of the medicinal product TFI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/aumed.cz\\\/#website\",\"url\":\"https:\\\/\\\/aumed.cz\\\/\",\"name\":\"Aumed, a.s.\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/aumed.cz\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/aumed.cz\\\/#\\\/schema\\\/person\\\/bc33bf2b3820f9b1a79abf1f5d855f94\",\"name\":\"Marek Vronka\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/499ea8661addfd9ad442ffcdffba6361521a11f58af0e25548a2234c5c6f92bb?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/499ea8661addfd9ad442ffcdffba6361521a11f58af0e25548a2234c5c6f92bb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/499ea8661addfd9ad442ffcdffba6361521a11f58af0e25548a2234c5c6f92bb?s=96&d=mm&r=g\",\"caption\":\"Marek Vronka\"},\"url\":\"https:\\\/\\\/aumed.cz\\\/en\\\/author\\\/mvro\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AUMED, a.s. has received permission for a clinical trial, phase III, of the medicinal product TFI - Aumed, a.s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/","og_locale":"en_US","og_type":"article","og_title":"AUMED, a.s. has received permission for a clinical trial, phase III, of the medicinal product TFI - Aumed, a.s.","og_description":"Based on the submitted application and the supplied documents, the State Institute for Drug Control (Czech Republic) has authorized a...","og_url":"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/","og_site_name":"Aumed, a.s.","article_published_time":"2025-01-16T11:38:57+00:00","article_modified_time":"2025-01-16T11:38:59+00:00","og_image":[{"width":5075,"height":2822,"url":"https:\/\/aumed.cz\/wp-content\/uploads\/2022\/05\/lyof-tablety-v\u00fdsledek-TRIA.jpg","type":"image\/jpeg"}],"author":"Marek Vronka","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marek Vronka","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/#article","isPartOf":{"@id":"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/"},"author":{"name":"Marek Vronka","@id":"https:\/\/aumed.cz\/#\/schema\/person\/bc33bf2b3820f9b1a79abf1f5d855f94"},"headline":"AUMED, a.s. has received permission for a clinical trial, phase III, of the medicinal product TFI","datePublished":"2025-01-16T11:38:57+00:00","dateModified":"2025-01-16T11:38:59+00:00","mainEntityOfPage":{"@id":"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/"},"wordCount":122,"image":{"@id":"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/#primaryimage"},"thumbnailUrl":"https:\/\/aumed.cz\/wp-content\/uploads\/2022\/05\/lyof-tablety-v\u00fdsledek-TRIA.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/","url":"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/","name":"AUMED, a.s. has received permission for a clinical trial, phase III, of the medicinal product TFI - Aumed, a.s.","isPartOf":{"@id":"https:\/\/aumed.cz\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/#primaryimage"},"image":{"@id":"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/#primaryimage"},"thumbnailUrl":"https:\/\/aumed.cz\/wp-content\/uploads\/2022\/05\/lyof-tablety-v\u00fdsledek-TRIA.jpg","datePublished":"2025-01-16T11:38:57+00:00","dateModified":"2025-01-16T11:38:59+00:00","author":{"@id":"https:\/\/aumed.cz\/#\/schema\/person\/bc33bf2b3820f9b1a79abf1f5d855f94"},"breadcrumb":{"@id":"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/#primaryimage","url":"https:\/\/aumed.cz\/wp-content\/uploads\/2022\/05\/lyof-tablety-v\u00fdsledek-TRIA.jpg","contentUrl":"https:\/\/aumed.cz\/wp-content\/uploads\/2022\/05\/lyof-tablety-v\u00fdsledek-TRIA.jpg","width":5075,"height":2822},{"@type":"BreadcrumbList","@id":"https:\/\/aumed.cz\/aumed-a-s-ziskal-povoleni-na-klinickou-studii-faze-iii-leciveho-pripravku-tfi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Dom\u016f","item":"https:\/\/aumed.cz\/en\/"},{"@type":"ListItem","position":2,"name":"AUMED, a.s. has received permission for a clinical trial, phase III, of the medicinal product TFI"}]},{"@type":"WebSite","@id":"https:\/\/aumed.cz\/#website","url":"https:\/\/aumed.cz\/","name":"Aumed, a.s.","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aumed.cz\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/aumed.cz\/#\/schema\/person\/bc33bf2b3820f9b1a79abf1f5d855f94","name":"Marek Vronka","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/499ea8661addfd9ad442ffcdffba6361521a11f58af0e25548a2234c5c6f92bb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/499ea8661addfd9ad442ffcdffba6361521a11f58af0e25548a2234c5c6f92bb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/499ea8661addfd9ad442ffcdffba6361521a11f58af0e25548a2234c5c6f92bb?s=96&d=mm&r=g","caption":"Marek Vronka"},"url":"https:\/\/aumed.cz\/en\/author\/mvro\/"}]}},"_links":{"self":[{"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/posts\/1805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/comments?post=1805"}],"version-history":[{"count":1,"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/posts\/1805\/revisions"}],"predecessor-version":[{"id":1806,"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/posts\/1805\/revisions\/1806"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/media\/1604"}],"wp:attachment":[{"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/media?parent=1805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/categories?post=1805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aumed.cz\/en\/wp-json\/wp\/v2\/tags?post=1805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}